Clinical Trials Directory

Trials / Completed

CompletedNCT03836898

Presbyopic Phakic Intraocular Lens for Myopia Correction

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
10 (actual)
Sponsor
Gemini Eye Clinic · Industry
Sex
All
Age
38 Years – 50 Years
Healthy volunteers
Not accepted

Summary

This is a prospective single-center study of implantations of the presbyopic version of phakic intraocular lens IPCL (EyeolUK, United Kingdom).

Detailed description

Participants are impanted with the phakic intraocular lens IPCL (EyeolUK, United Kingdom) and monitored during 2 years period. Visual acuity for near and distance is evaluated, along with refraction and endothelium cell density.

Conditions

Interventions

TypeNameDescription
DEVICEPresbyopic posterior chamber phakic intraocular lens IPCLPresbyopic posterior chamber phakic intraocular lens IPCL (EyeolUK, United Kingdom) has a refractive optic and diffractive trifocal pattern on its anterior optical surface to correct both distance and near refractive errors. Presbyopic addition is manufactured in a range of +1.0 to + 4.0 diopters (D) in 0.5 D steps.

Timeline

Start date
2016-01-01
Primary completion
2018-12-31
Completion
2018-12-31
First posted
2019-02-11
Last updated
2019-05-10

Locations

1 site across 1 country: Czechia

Source: ClinicalTrials.gov record NCT03836898. Inclusion in this directory is not an endorsement.